Clinical Trial: Study of SGR-1505 in Mature B-Cell Neoplasms
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mature B-Cell Neoplasm
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Open-Label, Multicenter, Dose Escalation Study of SGR-1505 as Monotherapy in Subjects With Mature B-Cell Malignancies
Brief Summary:
The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) and/or recommended dose (RD) of SGR-1505.
Read more